Literature DB >> 15292267

Functional characterization of a P2X receptor from Schistosoma mansoni.

Kelvin C Agboh1, Tania E Webb, Richard J Evans, Steven J Ennion.   

Abstract

The cloning and characterization of a P2X receptor (schP2X) from the parasitic blood fluke Schistosoma mansoni provides the first example of a non-vertebrate ATP-gated ion channel. A number of functionally important amino acid residues conserved throughout vertebrate P2X receptors, including 10 extracellular cysteines, aromatic and positively charged residues involved in ATP recognition, and a consensus protein kinase C site in the amino-terminal tail, are also present in schP2X. Overall, the amino acid sequence identity of schP2X with human P2X(1-7) receptors ranges from 25.8 to 36.6%. ATP evoked concentration-dependent currents at schP2X channels expressed in Xenopus oocytes with an EC(50) of 22.1 microM. 2',3'-O-(4-Benzoylbenzoyl)adenosine 5'-triphosphate (Bz-ATP) was a partial agonist (maximum response 75.4 +/- 4.4% that of ATP) with a higher potency (EC(50) of 3.6 microM) than ATP. Suramin and pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid blocked schP2X responses to 100 microm ATP with IC(50) values of 9.6 and 0.5 microM, respectively. Ivermectin (10 microM) potentiated currents to both ATP and Bz-ATP by approximately 60% with a minimal effect on potency (EC(50) of 18.2 and 1.6 microM, respectively). The relative permeability of schP2X expressed in HEK293 cells to various cations was determined under bi-ionic conditions. schP2X has a relatively high calcium permeability (P(Ca)/P(Na) = 3.80 +/- 0.29) and an estimated minimum pore diameter similar to that of vertebrate P2X receptors. SchP2X provides a useful comparative model for the better understanding of human P2X receptor function and may also provide an alternative drug target for treatment of schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292267     DOI: 10.1074/jbc.M408203200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Allosteric modulation of ATP-gated P2X receptor channels.

Authors:  Claudio Coddou; Stanko S Stojilkovic; J Pablo Huidobro-Toro
Journal:  Rev Neurosci       Date:  2011-03-16       Impact factor: 4.353

2.  Discovery of purinergic signalling, the initial resistance and current explosion of interest.

Authors:  G Burnstock
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 3.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

4.  A mechanism of intracellular P2X receptor activation.

Authors:  Venketesh Sivaramakrishnan; Samuel J Fountain
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

Review 5.  Biophysics of P2X receptors.

Authors:  Terrance M Egan; Damien S K Samways; Zhiyuan Li
Journal:  Pflugers Arch       Date:  2006-05-13       Impact factor: 3.657

6.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

Review 7.  Regulation of ATP-gated P2X channels: from redox signaling to interactions with other proteins.

Authors:  Stanko S Stojilkovic; Elías Leiva-Salcedo; Milos B Rokic; Claudio Coddou
Journal:  Antioxid Redox Signal       Date:  2013-09-25       Impact factor: 8.401

Review 8.  Unresolved issues and controversies in purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  J Physiol       Date:  2008-05-22       Impact factor: 5.182

9.  Evidence for Extracellular ATP as a Stress Signal in a Single-Celled Organism.

Authors:  Venketesh Sivaramakrishnan; Samuel J Fountain
Journal:  Eukaryot Cell       Date:  2015-06-05

10.  The Xenopus oocyte: a single-cell model for studying Ca2+ signaling.

Authors:  Yaping Lin-Moshier; Jonathan S Marchant
Journal:  Cold Spring Harb Protoc       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.